Ann: CMO Appointment and Clinical Trials Update, page-160

I absolutely agree with you @MandB. Whilst PIQ have there own things going on, DXB + PIQ Promarker D is the ultimate package deal for predictive CKD & early treatment, hence either delaying or reversing (hopefully) later stages of CKD. This is huge! I’m so glad that others see that. There are a few of us invested mutually with both companies. .

I know I’ve posted recent articles here b4, however for new people...you can see why & this is only in the USA. Patent licences until 2030 as @Aqua65. The rise in type 2 diabetes is a big health problem.

Fast tracking for CKD trials, it’s a huge problem. Looking at the big picture here: https://www.prnewswire.com/news-rel...-treatments-for-kidney-disease-300615267.html